Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Urovant Sciences Ltd

(NASDAQ: UROV)
Add to Portfolio
-0.02 (-0.26%)
as of 09:30 EDT

Last 7.79
Change -0.02 (-0.26%)
Open 7.79
Prev. Close 7.81
Today's Range
7.79
7.79
52wk Range
4.05
14.49
Volume 136
Avg Volume 28,127
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
UROV -0.26% +3.18% -33.13%
DJIA -1.92% -1.44% +0.29%
S&P 500 -2.06% -1.02% +0.18%

Key Statistics

Annual EPS -4.00
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 236,350
Weighted Alpha -36.40
Standard Deviation -0.09
Profit Margin N/A
Beta N/A

Growth Rates

YTD +18.21%

Opinion

Sell Hold Buy

Recent Headlines

Urovant Sciences Appoints James Robinson to its Board

BusinessWire via COMTEX - Wed Mar 06, 08:00AM EST
Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced James Robinson, President and(full story)
UROV: 7.79 (-0.02), ALKS: 20.42 (-0.95)